Research commercialisation opportunities

Two diamonds and reflections

Researchers at the University of Melbourne have developed new technologies that help to solve pressing challenges. You can license these technologies for your business, organisation or government department. We have technologies that can be used for the environment, information and communication, diagnostics, biotechnology, engineering and more. Browse the University's technologies that are available for licensing, and keep up to date with technologies that have been recently licensed.

Available for licensing

A macro of a silicon wafer. Each shiny coloured square is a chip with microscopic transistors and circuits.

Chip design methodology

The chip design methodology improves cybersecurity of low-power devices such as smart cards. Partner with us to accelerate development through licensing or co-development.

Green microscopic view of microalgae. image: Wikicommons

Microalgae fractionation method

Microalgae produce components that have commercial use. This new method of extraction is more cost effective and environmentally friendly than other methods.

Pink drug-resistant Neisseria gonorrhoeae bacteria on a blue background

Star-shaped polypeptides

University of Melbourne researchers have created star-shaped polypeptides. Partner with us to accelerate this anti-bacterial technology.

Side by side image showing pixel and colour degeneration on an image

Plasmonic pixel

Speed up development of this new pixel design, based on plasmonic nanostructures. It can detect the intensity of light across many wavelengths.

Predicting landslides

Predicting landslides

New open-pit mining technology predicts landslides up to 15 days in advance. Talk to us about licensing or direct investment opportunities.

Recently licensed

A number of pill packets and loose pills of different shapes and colours


A company has recently partnered with us to develop a new pain treatment technology that blocks CCL17 expression. This treatment can improve pain for chronic conditions.

Animation showing the mechanical activation of TGF-beta protein

Severe asthma therapy

This severe asthma therapy enhances steroid activity, without autoimmune or cardiac toxicities. We have recently partnered with a start-up to speed up therapy development.